BACKGROUND: Breast cancer is the most prevalent form of cancer worldwide, with 2.3 million new diagnoses in 2022. Recent advancements in treatment have led to a shift in the use of chemotherapy-targeted immunotherapy from a postoperative adjuvant to ...
This study sought to develop a radiomics model capable of predicting axillary lymph node metastasis (ALNM) in patients with invasive breast cancer (IBC) based on dual-sequence magnetic resonance imaging(MRI) of diffusion-weighted imaging (DWI) and dy...
Digital pathology enables automatic analysis of histopathological sections using artificial intelligence. Automatic evaluation could improve diagnostic efficiency and find associations between morphological features and clinical outcome. For developm...
Mathematical models are conventionally used to understand the of tumor behaviors, but they generally lack in precisely correlating drug efficacy with tumor response. Artificial intelligence (AI) has forged a new avenue in cancer management, but requi...
Artificial intelligence (AI), and image processing fields play a vital role in classifying benign and malignant breast cancer (BC). The novelty of this paper lies in computing original hybrid features (HF) from textural and shape features of BC integ...
BACKGROUND: Prognostic tools for determining patients with indolent breast cancers (BCs) are far from optimal, leading to extensive overtreatment. Several studies have demonstrated mRNAs, lncRNAs and miRNAs to have prognostic potential in BC. Because...
Nowadays, breast cancer is one of the leading causes of death among women. This highlights the need for precise X-ray image analysis in the medical and imaging fields. In this study, we present an advanced perceptual deep learning framework that extr...
Molecular biostatistical workflows in oncology often rely on predictive models that use multimodal data. Advances in deep learning and artificial intelligence technologies have enabled the multimodal fusion of large volumes of multimodal data. Here, ...
The immune response to tumour development is frequently targeted with therapeutics but remains largely unexplored in diagnostics, despite being stronger for early-stage tumours. We present an immunodiagnostic platform to detect this. We identify a pa...
Breast cancer remains the most prevalent cause of cancer-related mortality among women worldwide, with an estimated incidence exceeding 500,000 new cases annually. Timely diagnosis is vital for enhancing therapeutic outcomes and increasing survival p...
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.